Get ready to glow visible results in just 5 days
GLP-1 medications can interrupt this cycle
As of December 2024, the FDA approved tirzepatide for treatment of moderate-to-severe obstructive sleep apnea (OSA) in patients with obesity based on the results of two trials
"With the approval of the Wegovy pill, patients now have access to a once-daily oral option that delivers weight loss results comparable to injectable Wegovy," said Mike Doustdar, President and CEO of Novo Nordisk, in the company's official statement
Symptoms occur within minutes to seconds and involve cardiovascular, respiratory, and neurological changes
Different Types of GLP-1 Medications There are several types of GLP-1 medications available, each with varying dosing schedules and forms of administration